Study results point to efficacy of once-daily bimatoprost

March 1, 2002

Indianapolis-Pooled 6-month data from two multicenter, double-blind, parallel studies demonstrate that once-daily treatment with bimatoprost ophthalmic solution 0.03% (Lumigan, Allergan) is safe and more effective than timolol 0.5% for controlling elevated IOP, said Louis B. Cantor, MD.